May 12, 2016 4:05 pm EDT Capricor Therapeutics Provides Corporate Update and Reports First Quarter 2016 Financial Results
May 05, 2016 4:05 pm EDT Capricor Therapeutics to Hold First Quarter 2016 Business Update and Financial Results Conference Call on May 12, 2016 at 4:30 p.m. EDT
Apr 04, 2016 8:30 am EDT Capricor Therapeutics Announces DSMB Recommends Continuation of HOPE-Duchenne Clinical Trial
Mar 17, 2016 4:00 pm EDT Capricor Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update
Mar 17, 2016 12:50 pm EDT Capricor Awarded $3.4 Million Grant from California Institute for Regenerative Medicine
Mar 10, 2016 8:00 am EST Capricor Therapeutics to Hold Fourth Quarter 2015 Financial Results and Business Update Conference Call on March 17, 2016 at 4:30 p.m. EDT
Feb 23, 2016 9:00 am EST Capricor Therapeutics Appoints Leland J. Gershell, M.D., Ph.D. as Chief Financial Officer
Feb 22, 2016 8:00 am EST Capricor Therapeutics Announces the First Patient with Duchenne Muscular Dystrophy-Related Cardiomyopathy Treated with CAP-1002 in the HOPE-Duchenne Phase I/II Clinical Trial